Moneycontrol PRO
UPCOMING EVENT:Join us for New HorAIzon on Oct-7, 2pm and be a part of exciting conversations on tech & innovation
you are here: HomeNewsBusiness

Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher

Net Sales are expected to increase by 26.8 percent Y-o-Y (down 9.7 percent Q-o-Q) to Rs 547.6 crore, according to Prabhudas Lilladher.

October 06, 2021 / 05:39 PM IST
Dr Lal Pathlabs 

Dr Lal Pathlabs 

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Dr. Lal PathLabs to report net profit at Rs 112 crore up 28.4% year-on-year (up 16.2% quarter-on-quarter).


Net Sales are expected to increase by 26.8 percent Y-o-Y (down 9.7 percent Q-o-Q) to Rs 547.6 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 24.8 percent Y-o-Y (down 16 percent Q-o-Q) to Rs 158.8 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark